Complete Genome Sequence and Comparative Genomics of the Probiotic Yeast Saccharomyces Boulardii

Overview

Journal Sci Rep

Specialty Science

Date 2017 Mar 25

PMID 28336969

Citations 49

Authors

Indu Khatri

Rajul Tomar

K Ganesan

G S Prasad

Srikrishna Subramanian

Affiliations

Soon will be listed here.

Abstract

The probiotic yeast, Saccharomyces boulardii (Sb) is known to be effective against many gastrointestinal disorders and antibiotic-associated diarrhea. To understand molecular basis of probiotic-properties ascribed to Sb we determined the complete genomes of two strains of Sb i.e. Biocodex and unique28 and the draft genomes for three other Sb strains that are marketed as probiotics in India. We compared these genomes with 145 strains of S. cerevisiae (Sc) to understand genome-level similarities and differences between these yeasts. A distinctive feature of Sb from other Sc is absence of Ty elements Ty1, Ty3, Ty4 and associated LTR. However, we could identify complete Ty2 and Ty5 elements in Sb. The genes for hexose transporters HXT11 and HXT9, and asparagine-utilization are absent in all Sb strains. We find differences in repeat periods and copy numbers of repeats in flocculin genes that are likely related to the differential adhesion of Sb as compared to Sc. Core-proteome based taxonomy places Sb strains along with wine strains of Sc. We find the introgression of five genes from Z. bailii into the chromosome IV of Sb and wine strains of Sc. Intriguingly, genes involved in conferring known probiotic properties to Sb are conserved in most Sc strains.

Citing Articles

Alleviates Colitis by Regulating FXR-NLRP3 Mediated Macrophage Pyroptosis.

Yang L, Li W, Zhao Q, Mo Q, Liu T, Cao H J Inflamm Res. 2025; 18:3161-3176.

PMID: 40065908 PMC: 11891491. DOI: 10.2147/JIR.S504957.

Engineering Saccharomyces cerevisiae for medical applications.

Maneira C, Chamas A, Lackner G Microb Cell Fact. 2025; 24(1):12.

PMID: 39789534 PMC: 11720383. DOI: 10.1186/s12934-024-02625-5.

A comprehensive review on probiotics and their use in aquaculture: Biological control, efficacy, and safety through the genomics and wet methods.

Calcagnile M, Tredici S, Alifano P Heliyon. 2024; 10(24):e40892.

PMID: 39735631 PMC: 11681891. DOI: 10.1016/j.heliyon.2024.e40892.

High-Resolution Melting Analysis Potential for var. Authentication in Probiotic-Enriched Food Matrices.

Borkowska M, Kulakowski M, Myszka K BioTech (Basel). 2024; 13(4).

PMID: 39584905 PMC: 11586983. DOI: 10.3390/biotech13040048.

A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden.

Rebeck O, Wallace M, Prusa J, Ning J, Evbuomwan E, Rengarajan S Cell Chem Biol. 2024; 32(1):98-110.e7.

PMID: 39571582 PMC: 11741927. DOI: 10.1016/j.chembiol.2024.10.013.

References

Plein K, Hotz J . Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea--a pilot study. Z Gastroenterol. 1993; 31(2):129-34. View

Lherm T, Monet C, Nougiere B, Soulier M, Larbi D, Le Gall C . Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med. 2002; 28(6):797-801. DOI: 10.1007/s00134-002-1267-9. View

Tiago F, Martins F, Souza E, Pimenta P, Araujo H, Castro I . Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics. J Med Microbiol. 2012; 61(Pt 9):1194-1207. DOI: 10.1099/jmm.0.042283-0. View

Wang T, Sun H, Zhang J, Liu Q, Wang L, Chen P . The establishment of Saccharomyces boulardii surface display system using a single expression vector. Fungal Genet Biol. 2013; 64:1-10. DOI: 10.1016/j.fgb.2013.11.006. View

Douradinha B, Reis V, Rogers M, Torres F, Evans J, Marques Jr E . Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii. Bioengineered. 2013; 5(1):21-9. PMC: 4008461. DOI: 10.4161/bioe.26271. View

Cassone M, Serra P, Mondello F, Girolamo A, Scafetti S, Pistella E . Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J Clin Microbiol. 2003; 41(11):5340-3. PMC: 262466. DOI: 10.1128/JCM.41.11.5340-5343.2003. View

McFarland L . Saccharomyces boulardii is not Saccharomyces cerevisiae. Clin Infect Dis. 1996; 22(1):200-1. DOI: 10.1093/clinids/22.1.200. View

Jambhekar A, Amon A . Control of meiosis by respiration. Curr Biol. 2008; 18(13):969-75. PMC: 2504020. DOI: 10.1016/j.cub.2008.05.047. View

Boles E, Hollenberg C . The molecular genetics of hexose transport in yeasts. FEMS Microbiol Rev. 1997; 21(1):85-111. DOI: 10.1111/j.1574-6976.1997.tb00346.x. View

10.

Chin C, Alexander D, Marks P, Klammer A, Drake J, Heiner C . Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods. 2013; 10(6):563-9. DOI: 10.1038/nmeth.2474. View

11.

Nadalin F, Vezzi F, Policriti A . GapFiller: a de novo assembly approach to fill the gap within paired reads. BMC Bioinformatics. 2012; 13 Suppl 14:S8. PMC: 3439727. DOI: 10.1186/1471-2105-13-S14-S8. View

12.

Castagliuolo I, Lamont J, Nikulasson S, Pothoulakis C . Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun. 1996; 64(12):5225-32. PMC: 174512. DOI: 10.1128/iai.64.12.5225-5232.1996. View

13.

HODGSON J, Berry D, JOHNSTON J . Discrimination by heat and proteinase treatments between flocculent phenotypes conferred on Saccharomyces cerevisiae by the genes FLO1 and FLO5. J Gen Microbiol. 1985; 131(12):3219-27. DOI: 10.1099/00221287-131-12-3219. View

14.

Edwards-Ingram L, Gent M, Hoyle D, Hayes A, Stateva L, Oliver S . Comparative genomic hybridization provides new insights into the molecular taxonomy of the Saccharomyces sensu stricto complex. Genome Res. 2004; 14(6):1043-51. PMC: 419782. DOI: 10.1101/gr.2114704. View

15.

Hyle J, Shaw R, Reines D . Functional distinctions between IMP dehydrogenase genes in providing mycophenolate resistance and guanine prototrophy to yeast. J Biol Chem. 2003; 278(31):28470-8. PMC: 3367515. DOI: 10.1074/jbc.M303736200. View

16.

Dubois E, Jacobs E, Jauniaux J . Expression of the ROAM mutations in Saccharomyces cerevisiae: involvement of trans-acting regulatory elements and relation with the Ty1 transcription. EMBO J. 1982; 1(9):1133-9. PMC: 553174. DOI: 10.1002/j.1460-2075.1982.tb01308.x. View

17.

Warmington J, Green R, Newlon C, Oliver S . Polymorphisms on the right arm of yeast chromosome III associated with Ty transposition and recombination events. Nucleic Acids Res. 1987; 15(21):8963-82. PMC: 306416. DOI: 10.1093/nar/15.21.8963. View

18.

Surawicz C, McFarland L, Elmer G, CHINN J . Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol. 1989; 84(10):1285-7. View

19.

Buts J, de Keyser N, De Raedemaeker L . Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines. Pediatr Res. 1994; 36(4):522-7. DOI: 10.1203/00006450-199410000-00019. View

20.

Bruckner S, Mosch H . Choosing the right lifestyle: adhesion and development in Saccharomyces cerevisiae. FEMS Microbiol Rev. 2011; 36(1):25-58. DOI: 10.1111/j.1574-6976.2011.00275.x. View